These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3069983)

  • 21. Cocaine, dopamine and the endogenous opioid system.
    Kreek MJ
    J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking.
    Velázquez-Sánchez C; Ferragud A; Ramos-Miguel A; García-Sevilla JA; Canales JJ
    Addict Biol; 2013 Jul; 18(4):633-43. PubMed ID: 22741574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats.
    Sizemore GM; Davies HM; Martin TJ; Smith JE
    Drug Alcohol Depend; 2004 Mar; 73(3):259-65. PubMed ID: 15036548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Principles of the pharmacological treatment of drug addiction].
    Saadan M; Scuvée-Moreau J; Seutin V
    Rev Med Liege; 2013; 68(5-6):245-51. PubMed ID: 23888572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiate and cocaine dependencies. Techniques to help counter the rising tide.
    Washton AM; Gold MS; Pottash AC
    Postgrad Med; 1985 Apr; 77(5):293-7, 300. PubMed ID: 3983028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic approaches to the treatment of cocaine dependence.
    Taylor WA; Gold MS
    West J Med; 1990 May; 152(5):573-7. PubMed ID: 1971975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addiction pharmacotherapy 2000: new options, new challenges.
    Rawson RA; McCann MJ; Hasson AJ; Ling W
    J Psychoactive Drugs; 2000; 32(4):371-8. PubMed ID: 11210198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.
    Zernig G; Ahmed SH; Cardinal RN; Morgan D; Acquas E; Foltin RW; Vezina P; Negus SS; Crespo JA; Stöckl P; Grubinger P; Madlung E; Haring C; Kurz M; Saria A
    Pharmacology; 2007; 80(2-3):65-119. PubMed ID: 17570954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
    Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
    Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptor agonists, partial agonists and psychostimulant addiction.
    Pulvirenti L; Koob GF
    Trends Pharmacol Sci; 1994 Oct; 15(10):374-9. PubMed ID: 7809953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cocaine. Diagnosis and treatment.
    Weddington WW
    Psychiatr Clin North Am; 1993 Mar; 16(1):87-95. PubMed ID: 8456049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuncts to opioid therapy.
    Goldstein FJ
    J Am Osteopath Assoc; 2002 Sep; 102(9 Suppl 3):S15-21. PubMed ID: 12356036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating crack cocaine dependence: the critical role of relapse prevention.
    Wallace BC
    J Psychoactive Drugs; 1992; 24(2):213-22. PubMed ID: 1507002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opponent process model and psychostimulant addiction.
    Koob GF; Caine SB; Parsons L; Markou A; Weiss F
    Pharmacol Biochem Behav; 1997 Jul; 57(3):513-21. PubMed ID: 9218276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating crack cocaine dependence: the critical role of relapse prevention.
    Wallace BC
    J Psychoactive Drugs; 1990; 22(2):149-58. PubMed ID: 2197391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone and Addiction.
    Yadid G; Ahdoot-Levi H; Bareli T; Maayan R; Weizman A
    Vitam Horm; 2018; 108():385-412. PubMed ID: 30029736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pharmacology for addiction medicine: From evidence to clinical recommendations.
    Quednow BB; Herdener M
    Prog Brain Res; 2016; 224():227-50. PubMed ID: 26822361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.